| Typicality: | 0.372 |
| Saliency: | 0.059 |
| with another therapeutic agent | 4 | other |
| to effect altered permeability | 3 | purpose |
| composition → be administered in → combination | 4 |
| negative | neutral | positive |
| 0.052 | 0.901 | 0.047 |
| Raw frequency | 4 |
| Normalized frequency | 0.059 |
| Modifier score | 0.800 |
| Perplexity | 163.746 |